Spruce Biosciences appoints Adrian Quartel as new chief medical officer
Spruce Biosciences announced that Adrian Quartel has joined the company as its chief medical officer, after previously holding the same position at Zevra Therapeutics.
The biotech firm Spruce Biosciences confirmed the hiring of Adrian Quartel to serve as chief medical officer. Quartel comes to Spruce from Zevra Therapeutics, where he also led medical affairs. The move fills a senior leadership vacancy at Spruce. No additional details about his responsibilities were provided. The announcement was part of a regular feature highlighting personnel changes.
Why it matters
The appointment adds seasoned medical leadership to Spruce Biosciences, potentially shaping its drug development strategy.
In this story
chief medical officerhiringexecutive appointmentbiotechleadership transition
